Accelerating COVID-19 research through state-of-the-art preclinical, clinical diagnostics
and global supply chain services
As SARS-CoV-2 continues to spread across the globe, we are committed to provide support for finding an effective immune and prophylactic strategy. We are currently working on many SARS-CoV-2 anti-viral and vaccine clinical trials. Viroclinics-DDL build further on an impressive track record of pandemic related viral targets, including SARS-CoV-1 (2002-2004) and S-OIV (2009) using validated molecular, cellular and preclinical analyses models. As a virology focused CRO we have extensive expertise with high-demand scenarios. To assist the pharmaceutical, biotech and academic communities with the development of anti-viral medication and vaccines against SARS-CoV-2, Viroclinics-DDL offers a full suite of preclinical, clinical diagnostic and global supply chain services.
COVID-19 Service Proposition
Our service proposition includes:
Early stage and preclinical solutions
- Validated animal models for SARS-CoV-2 challenge studies using wild type virus in our BSL3 facilities
- Immunogenicity and efficacy testing
Virological Assays
- Viral culture/phenotyping
- Plaque assays (High through plaque reduction assay available, 96-well format)
Molecular Assays
- Next Generation Sequencing, whole genome, targeted, including Bio-IT
- Viral load qPCR
Clinical Trial Operations Services
- A global reach, through our network of 18 processing laboratories
- Production and distribution of sample kits, including vials, labels, forms and coding
- Global cold chain sample logistics.
COVID-19 News
Follow us on LinkedIn
Our contribution to science
Access peer reviewed articles
